Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

Microbial Pathogenesis

Volumn 5, Issue 2, 1988, Pages 127-139

  Welkos, Susan L ^a   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax; Bacillus subtilis recombinant; immunization; mice; protective antigen; Sterne

Indexed keywords

ANTHRAX; BACILLUS SUBTILIS; IMMUNIZATION; NONHUMAN;

ANIMAL; ANTIGENS, BACTERIAL; ANTITOXINS; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIAL TOXINS; BACTERIAL VACCINES; COMPARATIVE STUDY; IMMUNIZATION; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED STRAINS; RECOMBINATION, GENETIC; SPORES, BACTERIAL; VACCINES, ATTENUATED;

EID: 0023811218     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/0882-4010(88)90015-0     Document Type: Article

References (36)

1. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis
2. Efficacy of anthrax biologics in producing immunity in previously unexposed animals
3. Immunization of cattle against experimental anthrax with alumprecipitated protective antigen or spore vaccine
4. Studies on anthrax vaccine prepared from nonencapsulated variants of Bacillus anthracis
5. Anthrax toxin
6. Anthrax toxin
7. Anthrax: the disease in relation to vaccines
8. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig
9. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity
10. Immunization studies with attenuated strains of Bacillus anthracis
11. Differences in susceptibility of inbred mice to Bacillus anthracis
12. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process
13. Demonstration of a capsule plasmid in Bacillus anthracis
14. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis
15. Evidence for plasmid-mediated toxin production in Bacillus anthracis
16. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis
17. Genetics of Bacillus anthracis
18. Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid
19. Cloning of the protective antigen gene of Bacillus anthracis
20. Value of field data for extrapolation in anthrax
21. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis
22. The use of inbred mice as models for the indication and differentiation of Bacillus anthracis strains
23. Current status of immunological adjuvants
24. Genetic control of natural resistance to nontuberculous mycobacterial infections in mice
25. Distribution, inheritance, and properties of an antigen, MuB1, and its relation to hemolytic complement
26. Genetic defect in secretion of complement C5 in mice
27. A neutrophil chemotactic factor from human C5a
28. Quantification of mouse macrophage chemotaxis in vitro, role of C5 for production of chemotactic activity
29. Immunological studies of anthrax. I. An index to determine quantitative immunization
30. The immunization of laboratory animals against anthrax
31. Immunity to anthrax: protective antigen present in cell-free culture filtrates
32. Comparison of graded and quantal virulence tests for Bacillus anthracis spores
33. Measurement of protein using bicinchoninic acid
34. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells
35. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
36. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines